// App-Quantinova.ai

3919 : Liquid biopsy derived organoids as a potential platform for personalized cancer therapy in metastatic prostate cancer

Researchers

Presenter

  • Lisanne Mout

Principal Investigators

  • Lisanne F. van Dessel

  • Jaco Kraan

  • Anouk C. de Jong

  • Rui P. Neves

  • Sigrun Erkens-Schulze

  • Anieta M. Siewerts

  • Job van Riet

  • Ronald de Wit

  • Stefan Sleijfer

  • Paul Hamberg

  • Yorick Sandberg

  • Peter A. te Boekhorst

  • Harmen J. van de Werken

  • John W. Martens

  • Nikolas H. Stoecklein

  • Wytske M. van Weerden

  • Martijn P. Lolkema

Medical Centers

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • University Hospital, Duesseldorf, Germany

  • Franciscus Gasthuis & Vllietland, Rotterdam, Netherlands

  • Maasstad Hospital Rotterdam, Rotterdam, Netherlands

Locations

  • Netherlands

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Phosphatase and tensin homolog

  • Circulating tumor cells

  • Epithelial Cell Adhesion Molecule

  • White Blood Cell

Drug/Treatment

  • Enzalutamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved